NK

Neil K. Warma

President and Chief Executive Officer

ProMIS Neurosciences

ProMIS Neurosciences Pipeline

DrugIndicationPhase
PMN310Alzheimer's DiseasePhase 1b
PMN442Amyotrophic Lateral Sclerosis (ALS)Preclinical
PMN331Parkinson's Disease / Multiple System AtrophyPreclinical